Improve Research Reproducibility A Bio-protocol resource
Concise Method
tooltip

Bacterial growth conditions.

AA Angus Angermeyer
SH Stephanie G. Hays
MN Maria H. T. Nguyen
FJ Fatema-tuz Johura
MS Marzia Sultana
MA Munirul Alam
KS Kimberley D. Seed
request Request a Protocol
ask Ask a question
Favorite

The bacterial strains and plasmids used in this study are listed in Table S1 in the supplemental material. All bacterial strains were grown at 37°C in LB (Fisher) with aeration or on LB agar plates. Antibiotics were used when appropriate (100 μg/mL streptomycin, 75 μg/mL kanamycin; 2.5 μg/mL chloramphenicol for V. cholerae and 25 μg/mL for E. coli). Ectopic expression constructs in V. cholerae were induced 20 min prior to ICP1 infection with 1 mM isopropyl β-d-1-thiogalactopyranoside (IPTG) and 1.5 mM theophylline.

Copyright and License information:  ©2022 Angermeyer et al.
This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A